Preliminary study on the safety and efficacy of Donafenib as adjuvant therapy of patients with hepatocellular carcinoma at a high risk of recurrence after hepatectomy

ZHANG Shen-yu; SONG Rui-peng; WANG Wei

doi:10.19538/j.cjps.issn1005-2208.2023.04.07

Home>Articles>Preliminary study on the safety and efficacy of Donafenib as adjuvant therapy of patients with hepatocellular carcinoma at a high risk of recurrence after hepatectomy

DOI: 10.19538/j.cjps.issn1005-2208.2023.04.07

Preliminary study on the safety and efficacy of Donafenib as adjuvant therapy of patients with hepatocellular carcinoma at a high risk of recurrence after hepatectomy

ZHANG Shen-yu

SONG Rui-peng

WANG Wei

Machine-generated Keywords：

Publication Date：2023-04-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 401-404 )

Chinese Journal of Practical Surgery

ISTICPKU

ISSN：1005-2208

Year, Vol.(Issue)：2023,43(4)